Zobrazeno 1 - 10
of 845
pro vyhledávání: '"Janet E, Pope"'
Autor:
Peter C. Taylor, Eugen Feist, Janet E. Pope, Peter Nash, Jean Sibilia, Roberto Caporali, Alejandro Balsa
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 16 (2024)
Rheumatoid arthritis (RA) is an autoimmune disease characterised by persistent inflammation of the synovial joints as well as other tissues and organs. Left untreated, it can lead to joint damage, disability and even increased mortality. The disease
Externí odkaz:
https://doaj.org/article/d96feea0ed454c218a7683db71ca7baa
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 4, Pp 173-179 (2023)
Objective To describe the pattern and risk factors for antimalarial (AM)‐induced retinopathy in patients with rheumatic diseases. Methods A retrospective chart review was conducted at an urban Canadian center for patients with AM use of more than 3
Externí odkaz:
https://doaj.org/article/08d7e5e530cb42018b427a4d99095f2b
Autor:
Janet E. Pope, Yvonne C. Lee, Jeffrey R. Curtis, Daojun Mo, Li Xie, Christina L. Dickson, Douglas E. Schlichting, Anabela Cardoso, Lee S. Simon, Peter C. Taylor
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 3, Pp 254-258 (2022)
Objective Pain reduction with baricitinib was assessed in patients with rheumatoid arthritis (RA) who either used opioids or did not use opioids during three randomized, double‐blind phase 3 trials. Methods Analysis populations were as follows: i)
Externí odkaz:
https://doaj.org/article/86a87bdaa02641a29f900d98f08520ca
Autor:
Janet E Pope, Johannes Roth, Earl D Silverman, Roberta A Berard, Deborah M Levy, Steve Jeoung, J Carter Thorne
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/ba69a828d52b4e69a4bfa4dc8cd80b0d
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The pathogenesis of connective tissue diseases (CTDs), such as systemic lupus erythematosus (SLE) and systemic sclerosis (SSc), is characterized by derangements of the innate and adaptive immune system, and inflammatory pathways leading to autoimmuni
Externí odkaz:
https://doaj.org/article/a771f5333549467a8a039521ea6c2d88
Autor:
Janet E Pope, Daniel J Wallace, Murray B Urowitz, Dafna D Gladman, Diane L Kamen, Christine A Peschken, Zahi Touma, Earl D Silverman, Mariko Ishimori, Andrew D Paterson, Deborah M Levy, Sylvia Kamphuis, Linda T Hiraki, Marisa S Klein-Gitelman, Jingjing Cao, Declan Webber, Daniela Dominguez, Andrea M Knight, Joan E Wither, Raffaella Carlomagno, Fangming Liao, Caroline Jefferies, Chia-Chi J Lee, Karen B Onel
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/05f5dfdd2ee04191a2084ef4d6f2b844
Autor:
Kaleb Michaud, Janet E. Pope, Paul Emery, Baojin Zhu, Carol L. Gaich, Amy M. DeLozier, Xiang Zhang, Christina L. Dickson, Josef S. Smolen
Publikováno v:
Rheumatology and Therapy, Vol 6, Iss 3, Pp 409-419 (2019)
Abstract Introduction To explore the relationship of pain and fatigue with daily activity and work productivity in rheumatoid arthritis (RA) patients from the baricitinib clinical trial, RA-BEAM. Methods In RA-BEAM, a double-blind phase 3 study, pati
Externí odkaz:
https://doaj.org/article/8cacdf64500b41d186f04a8d38da63dc
Autor:
Janet E. Pope, Edward Keystone, Shahin Jamal, Lisy Wang, Lara Fallon, John Woolcott, Irina Lazariciu, Douglass Chapman, Boulos Haraoui
Publikováno v:
ACR Open Rheumatology, Vol 1, Iss 2, Pp 73-82 (2019)
ABSTRACT Objective Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). This post hoc analysis evaluated tofacitinib persistence in patients with RA in long‐term extension (LTE) studies up to 9.5 years. Meth
Externí odkaz:
https://doaj.org/article/10a7f160ef4a4bb2979891238ac01951
Publikováno v:
Rheumatic Disease Clinics of North America. 49:401-410
Autor:
Janet E. Pope, Christopher P. Denton, Sindhu R. Johnson, Andreu Fernandez-Codina, Marie Hudson, Tatiana Nevskaya
Publikováno v:
Nature Reviews Rheumatology. 19:212-226